334 related articles for article (PubMed ID: 23670574)
1. Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation.
Suzuki N; Yamazaki S; Yamaguchi T; Okabe M; Masaki H; Takaki S; Otsu M; Nakauchi H
Mol Ther; 2013 Jul; 21(7):1424-31. PubMed ID: 23670574
[TBL] [Abstract][Full Text] [Related]
2. Activated HoxB4-induced hematopoietic stem cells from murine pluripotent stem cells via long-term programming.
Izawa K; Yamazaki S; Becker HJ; Bhadury J; Kakegawa T; Sakaguchi M; Tojo A
Exp Hematol; 2020 Sep; 89():68-79.e7. PubMed ID: 32795499
[TBL] [Abstract][Full Text] [Related]
3. In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells.
Amabile G; Welner RS; Nombela-Arrieta C; D'Alise AM; Di Ruscio A; Ebralidze AK; Kraytsberg Y; Ye M; Kocher O; Neuberg DS; Khrapko K; Silberstein LE; Tenen DG
Blood; 2013 Feb; 121(8):1255-64. PubMed ID: 23212524
[TBL] [Abstract][Full Text] [Related]
4. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Generation of Engraftable Murine Hematopoietic Stem Cells by Gfi1b, c-Fos, and Gata2 Overexpression within Teratoma.
Tsukada M; Ota Y; Wilkinson AC; Becker HJ; Osato M; Nakauchi H; Yamazaki S
Stem Cell Reports; 2017 Oct; 9(4):1024-1033. PubMed ID: 28943250
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells.
Heinz N; Ehrnström B; Schambach A; Schwarzer A; Modlich U; Schiedlmeier B
Stem Cells Transl Med; 2015 Sep; 4(9):1064-72. PubMed ID: 26160960
[TBL] [Abstract][Full Text] [Related]
7. OP9-Lhx2 stromal cells facilitate derivation of hematopoietic progenitors both in vitro and in vivo.
Chen X; Zhao Q; Li C; Geng Y; Huang K; Zhang J; Wang X; Yang J; Wang T; Xia C; Liu X; Meng M; Yang D; Zheng Y; Du J; Zhang X; Chen J; Pan G; Wang J
Stem Cell Res; 2015 Sep; 15(2):395-402. PubMed ID: 26339946
[TBL] [Abstract][Full Text] [Related]
8. Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor.
Tan YT; Ye L; Xie F; Beyer AI; Muench MO; Wang J; Chen Z; Liu H; Chen SJ; Kan YW
Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2180-2185. PubMed ID: 29386396
[TBL] [Abstract][Full Text] [Related]
9. Inability of human induced pluripotent stem cell-hematopoietic derivatives to downregulate microRNAs in vivo reveals a block in xenograft hematopoietic regeneration.
Risueño RM; Sachlos E; Lee JH; Lee JB; Hong SH; Szabo E; Bhatia M
Stem Cells; 2012 Feb; 30(2):131-9. PubMed ID: 22131151
[TBL] [Abstract][Full Text] [Related]
10. Serum- and stromal cell-free hypoxic generation of embryonic stem cell-derived hematopoietic cells in vitro, capable of multilineage repopulation of immunocompetent mice.
Lesinski DA; Heinz N; Pilat-Carotta S; Rudolph C; Jacobs R; Schlegelberger B; Klump H; Schiedlmeier B
Stem Cells Transl Med; 2012 Aug; 1(8):581-91. PubMed ID: 23197864
[TBL] [Abstract][Full Text] [Related]
11. Generation of induced pluripotent stem cells as a potential source of hematopoietic stem cells for transplant in PNH patients.
Phondeechareon T; Wattanapanitch M; U-Pratya Y; Damkham C; Klincumhom N; Lorthongpanich C; Kheolamai P; Laowtammathron C; Issaragrisil S
Ann Hematol; 2016 Oct; 95(10):1617-25. PubMed ID: 27465155
[TBL] [Abstract][Full Text] [Related]
12. The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.
Ou Z; Niu X; He W; Chen Y; Song B; Xian Y; Fan D; Tang D; Sun X
Sci Rep; 2016 Sep; 6():32463. PubMed ID: 27581487
[TBL] [Abstract][Full Text] [Related]
13. A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: blood-derived endothelial progenitor cells.
Geti I; Ormiston ML; Rouhani F; Toshner M; Movassagh M; Nichols J; Mansfield W; Southwood M; Bradley A; Rana AA; Vallier L; Morrell NW
Stem Cells Transl Med; 2012 Dec; 1(12):855-65. PubMed ID: 23283547
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive detection of human-induced pluripotent stem cell (hiPSC)-derived teratoma with an integrin-targeting agent (99m)Tc-3PRGD2.
Li Y; Liu Z; Dong C; He P; Liu X; Zhu Z; Jia B; Li F; Wang F
Mol Imaging Biol; 2013 Feb; 15(1):58-67. PubMed ID: 22707047
[TBL] [Abstract][Full Text] [Related]
15. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.
Araki R; Uda M; Hoki Y; Sunayama M; Nakamura M; Ando S; Sugiura M; Ideno H; Shimada A; Nifuji A; Abe M
Nature; 2013 Feb; 494(7435):100-4. PubMed ID: 23302801
[TBL] [Abstract][Full Text] [Related]
16. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
[TBL] [Abstract][Full Text] [Related]
17. In vitro generation of HSC-like cells from murine ESCs/iPSCs by enforced expression of LIM-homeobox transcription factor Lhx2.
Kitajima K; Minehata K; Sakimura K; Nakano T; Hara T
Blood; 2011 Apr; 117(14):3748-58. PubMed ID: 21343610
[TBL] [Abstract][Full Text] [Related]
18. Tu-mor(e) blood cells from human pluripotent stem cells.
Kaufman DS
Blood; 2013 Feb; 121(8):1245-6. PubMed ID: 23429981
[TBL] [Abstract][Full Text] [Related]
19. Generation of hematopoietic cells from mouse pluripotent stem cells in a 3D culture system of self-assembling peptide hydrogel.
Shan W; Wang B; Xu Y; Li X; Li X; Wang H; Lin Y; Tie R; Zhao Q; Wang J; Zheng W; Hu Y; Shi J; Yu X; Huang H
J Cell Physiol; 2020 Mar; 235(3):2080-2090. PubMed ID: 31389001
[TBL] [Abstract][Full Text] [Related]
20. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system.
Song B; Fan Y; He W; Zhu D; Niu X; Wang D; Ou Z; Luo M; Sun X
Stem Cells Dev; 2015 May; 24(9):1053-65. PubMed ID: 25517294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
